Loading chat...
KS SB236
Bill
Status
Failed
4/30/2024
Primary Sponsor
Public Health and Welfare
Click for details
AI Summary
Legislative Description
Requiring drug manufacturers to provide pricing under the federal 340B drug pricing program to pharmacies that enter into contractual agreements with entities covered under the 340B program and prohibiting pharmacy benefits managers from denying patients the freedom to use the pharmacy and healthcare provider of such patient's choice.
Last Action
Senate Died in Committee
4/30/2024
Committee Referrals
Financial Institutions and Insurance2/13/2023
Full Bill Text
No bill text available